NCT04454450View on ClinicalTrials.gov

Using Advanced Imaging Studies to Develop a Profile of High-grade Serous Ovarian Cancer

NAActive, not recruitingINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

June 22, 2020

Primary Completion Date

June 30, 2026

Study Completion Date

June 30, 2026

Conditions
Ovarian CancerHigh Grade Ovarian Serous
Interventions
DIAGNOSTIC_TEST

PET/MRI

Imaging will include research PET/MRI of pelvis within 30 days of multiregion tissue collection.For research PET/MRI - standard volumes of gadolinium contrast and fluorodeoxyglucose (FDG) will be administered.

DIAGNOSTIC_TEST

Contrast enhanced CT

Standard of care contrast enhanced CT

Trial Locations (1)

10065

Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York

All Listed Sponsors
lead

Memorial Sloan Kettering Cancer Center

OTHER